<p>Benitec Biopharma Inc. held its 2025 Annual Meeting of Stockholders on December 1, 2025. Stockholders elected Dr. Jerel Banks and Megan Boston to the board of directors. The appointment of the independent registered public accounting firm was ratified. All proposals brought before the meeting were approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Benitec Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-305475), on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

BNTC

<p>Benitec Biopharma Inc. held its 2025 Annual Meeting of Stockholders on December 1, 2025. Stockholders elected Dr. Jerel Banks and Megan Boston to the board of directors, ratified the appointment of the independent registered public accounting firm, and approved all proposals presented at the meeting.</p>

Benitec Biopharma Inc. held annual stockholder meeting